Certara Reports Fourth Quarter 2024 Financial Results Blog Post

February 26, 2025 Issues Full Year 2025 Financial Guidance RADNOR, PA – February 26, 2025 – Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today reported its financial results...

Behind the Science: A Conversation with Lamia Sid-Otmane Blog Post

You May Also Like AllVideo Blending Science & Impact in Drug Development: Felix Boakye-Agyeman, Vice President of the QSS Division at CertaraBlending Science & Impact in Drug Development: Felix Boakye-Agyeman,...

Libra Page

Libra™ is AI-powered drug-induced liver injury (DILI) modeling software for precise DILI prediction, reducing animal testing & optimizing preclinical workflows.

Chemaxon Page

A complete cheminformatics workbench for molecule design, property calculation, search, data management, and more.